1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive MutationsHarboring EGFR Sensitive Mutations NSCLC; Locally Advanced or Metastatic Non-squamous NSCLC; Previously Untreated Systematically NSCLCRecruitingPhase 32024-12-16NCT06735391